Oxcarbazepine and spasticity: further observations

Oxcarbazepine and spasticity: further observations

The previously described anti-spastic effect of oxcarbazepine and 10,11-dihydro-10-hydroxycarbamazepine was found accidentally in 2 patients undergoing a double-blind comparative study lor evaluation of antiepileptic effect. In this study oxcarbazepine was given orally in doses of 300-2700 mg daily...

Full description

Bibliographic Details
Main Author:	Paulo Rogério M. Bittencourt
Format:	Article
Language:	English
Published:	Academia Brasileira de Neurologia (ABNEURO) 1988-12-01
Series:	Arquivos de Neuro-Psiquiatria
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X1988000400008&lng=en&tlng=en

Similar Items

Oxcarbazepine Monotherapy
by: J Gordon Millichap
Published: (2006-10-01)

Oxcarbazepine in Monotherapy
by: Mogens Dam
Published: (1990-01-01)

Oxcarbazepine in Paroxysmal Dyskinesia
by: J Gordon Millichap
Published: (2009-04-01)

Carbamazepine and oxcarbazepine: reflections after an oxcarbazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap.
by: Poletti Jabbour, Jamil, et al.
Published: (2016)

Risk-Benefits of Oxcarbazepine vs Carbamazepine
by: J Gordon Millichap
Published: (2004-10-01)

Oxcarbazepine: validation and application of an analytical method
by: Paula Cristina Rezende Enéas, et al.
Published: (2010-06-01)

Oxcarbazepine Adjunctive Therapy for Partial Seizures
by: J Gordon Millichap
Published: (2000-07-01)

Varying AV Block Induced by Oxcarbazepine
by: Özcan Örsçelik, et al.
Published: (2018-09-01)

Oxcarbazepine: Drug of the future in the treatment of trigeminal neuralgia
by: Revant H Chole, et al.
Published: (2011-01-01)

Oxcarbazepine-induced hyponatremia: one case report
by: Xue-ning SU, et al.
Published: (2014-09-01)

A Case of Oxcarbazepine-Induced Severe Hyponatremia
by: Yıldız Değirmenci, et al.
Published: (2011-01-01)

Oxcarbazepine Therapy for Complete Central Diabetes Insipidus
by: Basmah Abdallah, et al.
Published: (2018-01-01)

Oxcarbazepine for refractory epilepsy: systematic review of the literature
by: Humberto Saconato, et al.

Nistagmus Downbeat Nystagmus Due to Oxcarbazepine Intoxication
by: Gül Yalçın Çakmaklı, et al.
Published: (2009-09-01)

Oxcarbazepine as the initial monotherapy of focal epilepsy in adolescents and adults
by: T. N. Pushkar, et al.
Published: (2021-06-01)

Cognitive Function During Oxcarbazepine Treatment for Partial Seizures
by: J Gordon Millichap
Published: (2006-10-01)

Nummular headache responding to oxcarbazepine: A rare case
by: Jalpan Patel, et al.
Published: (2020-01-01)

Oxcarbazepine Induced Maculopapular Rash - A Case Report
by: Arunava Biswas, et al.
Published: (2015-01-01)

Evaluation of hematologic profile may be needed for patients treated with oxcarbazepine
by: Gu Hyun Jung, et al.
Published: (2019-08-01)

Neurocognitive evaluation of oxcarbazepine monotherapy in children with benign chilhood epilepsy
by: Panteliadis Christos, et al.
Published: (2006-02-01)

A Structurally Diverse Heterocyclic Library by Decoration of Oxcarbazepine Scaffold
by: Giovanni Palmisano, et al.
Published: (2013-11-01)

Acute hepatotoxicity due to clonazepam in a girl using oxcarbazepine
by: Sinan AKBAYRAM, et al.
Published: (2013-01-01)

Oxcarbazepine-induced Stevens-Johnson Syndrome: A Case Report
by: Lung-Chang Lin, et al.
Published: (2009-02-01)

Oxcarbazepine-induced Stevens Johnson syndrome: A rare case report
by: S R Sharma, et al.
Published: (2011-01-01)

Evaluation of Factors Impacting the Efficacy of Single or Combination Therapies of Valproic Acid, Carbamazepine, and Oxcarbazepine: A Longitudinal Observation Study
by: Qilin Peng, et al.
Published: (2021-05-01)

Oxcarbazepine for Behavioral Disorders after Brain Injury: Factors Influencing Efficacy
by: Marco Pozzi, et al.
Published: (2021-07-01)

Reintroduction of oxcarbazepine after allergic reaction in two pediatric patients with epilepsy
by: Lingyan Yu, et al.
Published: (2021-08-01)

STATUS EPILEPTICUS INDUCED BY HYPONATREMIA AS AN ADVERSE REACTION TO OXCARBAZEPINE – CASE REPORT
by: Corina Roman-Filip, et al.
Published: (2012-12-01)

Why should we monitor for hematologic adverse drug reactions to oxcarbazepine?
by: Gwang Cheon Jang
Published: (2019-08-01)

First Analysis of the Association Between CYP3A4/5, ABCB1 Genetic Polymorphisms and Oxcarbazepine Metabolism and Transport in Chinese Epileptic Patients with Oxcarbazepine Monotherapy and Bitherapy
by: Wang Ping, et al.
Published: (2015-07-01)

Amiodarone Enhances Anticonvulsive Effect of Oxcarbazepine and Pregabalin in the Mouse Maximal Electroshock Model
by: Monika Banach, et al.
Published: (2021-01-01)

Hepatitis C-related cryoglobulinemic neuropathy: potential role of oxcarbazepine for pain control
by: Rita Moretti, et al.
Published: (2018-01-01)

Oxcarbazepine monotherapy in children with benign epilepsy with centrotemporal spikes improves quality of life
by: Wan-Ting Liu, et al.
Published: (2020-07-01)

Effect of oxcarbazepine on immune function, thyroid function and related factors in epilepsy patients
by: Chun-Yu Yu, et al.
Published: (2019-02-01)

The effect of oxcarbazepine on corticomotor excitability: correlation with plasma levels of the parent drug and metabolites
by: Imaz Kanaze, et al.
Published: (2006-02-01)

Titrimetric and Spectrophotometric Assay of Oxcarbazepine in Pharmaceuticals Using N-Bromosuccinimide and Bromopyrogallol Red
by: Nagaraju Rajendraprasad, et al.
Published: (2011-01-01)

Metabolic Characteristics of Oxcarbazepine (®Trileptal) and their Beneficial Implications for Enzyme Induction and Drug Interactions
by: Johann W. Faigle, et al.
Published: (1990-01-01)

Determination of oxcarbazepine and its related substances using UHPLC method with UV detection
by: Žirojević Jelena, et al.
Published: (2014-01-01)

Clinical application of blood concentration monitoring of active metabolite of oxcarbazepine in childhood focal epilepsy
by: Pei-yuan ZHANG, et al.
Published: (2018-06-01)

Development and validation of indirect visible spectrophotometric methods for oxcarbazepine in pure and the tablet dosage form
by: Hemavathi N. Deepakumari, et al.
Published: (2016-09-01)